WASHINGTON, DC – AdvaMed Accel released the following statement from Executive Director Ashley Wittorf on today’s hearing in the House Ways & Means Tax Policy Subcommittee on tax reform and small business growth:
Top News
Press Release | July 11, 2017
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker regarding the planned vote in the U.S. House on the FDA Reauthorization Act of 2017:
Press Release | June 26, 2017
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from Matthew Wetzel, vice president and assistant general counsel, regarding last week’s filing of an amicus curiae brief with the U.S. Supreme Court in the case of Ethicon v. Huskey:
Events
September
12
September 12, 2017 to September 14, 2017
| Washington, DC Register by August 4th and get $200 off of registration with Early-Bird pricing!
Join seasoned industry compliance leaders for two days of in-depth and interactive training where you’ll learn what... Read More
September
12
September 12, 2017 to September 14, 2017
| Shanghai, China The Healthcare Capital and Connections Summit is an exclusive three-day, invitation only opportunity to connect with the most relevant healthcare VCs, startups, large corporate and business partners... Read More
Featured Video
On June 8th AdvaMed brought together 21 member companies to showcase their latest breakthroughs in medical technology at the Capitol Visitors Center. The event was a bustling success with more than 150 people in attendance including policymakers, Hill staff, patient and provider groups, and media.
Industry News
PR Newswire
Bio2 Medical today announced the results of the Angel® Catheter pivotal study, "Evaluation of a Device Combining an Inferior Vena Cava Filter and a Central Venous Catheter for Preventing Pulmonary Embolism Among Critically Ill Trauma Patients," published in the Journal of Vascular and Interventional Radiology (JVIR). The Angel® Catheter met all safety endpoints and demonstrated a significant reduction in clinically significant and fatal pulmonary embolism (PE). The novel device was tested in a...
RealClear Health
Often undiagnosed, an estimated two to six million people in the United States have a serious heart condition called atrial fibrillation, or AFib. As those living with the disease know, complications from the irregular heartbeat caused by the AFib can be potentially devastating: The average person with AFib is five times more likely to suffer a stroke than someone with a regular heartbeat. Fortunately, there is innovative medical technology available today poised to make a real difference in...
Legal Backgrounder
When a doctor implants a medical device, he or she often requests the presence of a representative of the device manufacturer (a “rep”) in the operating room. Some observers are critical of this practice, demanding thatreps be barred from the O.R. At the same time,some lawyersthink repsin the O.R.should be subject to liability in the court system. This Legal Backgrounder explains why reps often play an important, if limited, role in the O.R., and why that role should not expose reps to lawsuits
Business Wire
ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today the closing of a $36 million Series C financing, including existing convertible notes. The round was led by Philips and UPMC, through its innovation and commercialization arm UPMC Enterprises, with other new and existing investors participating. The funding will support a planned US-based pivotal trial for...
Washington Examiner
Imagine for a moment that you are one of the approximately 44 million women in the U.S. affected by cardiovascular disease, or one of the 24 million with osteoarthritis. You'd want access to the most advanced and effective care. Oftentimes, your doctor would recommend a medical technology or device as an essential component of your treatment – placing a stent in a blocked artery or replacing your knee or hip with a new artificial one, for example.
Twitter Feed
July 24, 2017 - 12:20pm
Sessions in The #MedTechCon Industry Outlook & Insights pillar will tackle how to succeed in the constantly changing #medtech environment.
July 21, 2017 - 11:30am
Excellent advice from advocacy expert @JCScottAdvaMed of @AdvaMedUpdate in our new best practices guide:… https://t.co/AbvAq232n2